3SBio Inc. http://www.alacrastore.com/company-snapshot/3SBio_Inc-3918615 Saturday, August 30, 2008 4:17:20 AM 3918615 3SBio Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/ccbn/T1912497ccbn/T1912497norm... - Q# #### #SBio Inc. - CEOThank you, operator, and thanks, everyone, for joining us on our Second Quarter #### result conference call. Joining me today are Kevin Teo, Chief Financial Officer, David Chen, Chief Operating Officer, and Dr. Yingfei Wei, our Chief Scientific Officer. As we proceed through our remarks, we will refer our results presentation, which can be downloaded from our website at www.#sbio.com. Following an overview slide, the slide pertaining to the EPO market, and our results begin on page #. We're happy to report another quarter of top-line growth bolstered by continued positive momentum in our therapeutic end markets. Again, for reference, this included on slides # and #, an overview of, first, the historic growth in the Chinese EPO market, and second, data demonstrating the low penetration rates within the oncology market in China. I will not review these in detail again at this point. However, I would like to impart on you all the fact that, one, we expect the overall... 8/13/2008 11:04:00 PM3SBIO INC54.0000Final3SBIO INC Q2 2008 Earnings Conference Call TranscriptSSRX8:00am ETTranscriptT1912497Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-27354831newstex/PRN-0005-27354831xml SHENYANG, China, Aug. ##, #### (Xinhua-PRNewswire-FirstCall delivered by Newstex) -- #SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical...07000000070050000400000004016000040160480401601804016001040160030401601304002000040020060400600004006005040100000401000113000000130100001301000513001000130010021300200013002005070140000701400807014012070030000700300107001000070010048/12/2008 5:18:58 PM18000000180040001800800018020000180220001801500019000000190020001900200919002004190020131900100019001032PR Newswire USPRN-0005-273548313SBIO INC.SSRXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-27011824newstex/PRN-0005-27011824xml SHENYANG, China, Jul. ##, #### (Xinhua-PRNewswire-FirstCall delivered by Newstex) -- #SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical...040000000401600004016048040160180401600104002000040020060400200113000000130020001300200513010000130100057/29/2008 5:17:34 PM1800000018008000180040001900000019002000190020091900200419002013PR Newswire USPRN-0005-270118243SBIO INC.SSRXNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1831768ccbn/T1831768norm... - #SBio Inc. - CEOThank you operator. And thanks everyone for joining us on our first quarter #### results conference call. Joining me today are Kevin Teo, Chief Financial Officer, David Chen, Chief Operating Officer and Dr. Yingfei Wei, our Chief Scientific Officer. As we proceed through our remarks, we will refer to our results presentation which can we downloaded from our website at www.#sbio.com. Following an overview slide, the slide pertaining to the EPO market and our results begin on page five. I'm happy to report a record first quarter result highlighted by strong topline growth from our primary revenue drivers EPIAO and TPIAO and continued penetration from our IV-Iron product. We are pleased to see robust sales from our EPO franchise, which we believe was driven in large part by growth in both the oncology and nephrology end markets. To give you a better sense of the broader EPO market dynamics we've included a graph on slide six which shows that the EPO market in China as... 5/15/2008 6:04:00 PM3SBIO INC54.0000FinalQ1 2008 3SBIO INC Earnings Conference Call TranscriptSSRX8:00pm CCTTranscriptT1831768Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1756285ccbn/T1756285norm... - #SBio, Inc. - CEOThank you, operator, and good morning, everyone. Joining me today are Kevin Teo, our CHIEF FINANCIAL OFFICER, David Chen, our VP of Business Development and also Clara Mak, who, as you know, has been transitioning out of the role of CFO with her last day to be February ##th. Before we begin, I would like to thank Clara for all of her efforts and contributions to the continued success of #SBio. She has played a key role in the growth and development of the Company and has been a valuable asset to us throughout our first year as a public Company. It has been a pleasure working with you, Clara, and you will be missed. ... 2/21/2008 5:06:00 PM3SBIO INC54.0000FinalQ4 and FY 2007 3SBIO INC Earnings Conference Call TranscriptSSRX8:00am ETTranscriptT1756285Credit & Investment ResearchThomson Street Events